Keyphrases
Adenovirus
100%
HEC-RAS
100%
Therapeutic Efficacy
100%
Bladder Cancer
100%
Anti-H
100%
Ribozyme
100%
Tumor
50%
Tumor Inhibition
33%
Complete Regression
33%
Intralesional Injection
33%
Gene Therapy
16%
Cell Proliferation
16%
Viral Infection
16%
Point mutation
16%
Dose Effect
16%
Titer
16%
Tumorigenesis
16%
H-ras Oncogene
16%
Antisense Oligonucleotides
16%
Cytotoxicity
16%
Delivery Vehicle
16%
Observation Period
16%
Nude Mice
16%
Adenovirus Vector
16%
Urinary Bladder
16%
Subcutaneous Injection
16%
Recombinant Adenovirus
16%
Malignant Phenotype
16%
RAS Oncogene
16%
Human Bladder Cancer
16%
Antineoplastic Agents
16%
Inhibition Efficacy
16%
Bladder Cancer Model
16%
H-Ras Gene
16%
Hammerhead Ribozyme
16%
Bladder Carcinoma Cells
16%
Pharmacology, Toxicology and Pharmaceutical Science
Combination Therapy
100%
Adenoviridae
100%
Bladder Cancer
100%
Ribozyme
100%
Neoplasm
50%
Tumor Growth
16%
Carcinogenesis
16%
Recurrent Disease
16%
Cancer Model
16%
Adenovirus Vector
16%
Virus Infection
16%
Cancer Inhibition
16%
Nude Mouse
16%
Antisense Oligonucleotide
16%
Subcutaneous Injection
16%
Bladder Carcinoma
16%
Hammerhead Ribozyme
16%
Cytotoxicity
16%
Biochemistry, Genetics and Molecular Biology
Adenoviridae
100%
Ribozyme
100%
Oncogene Ras
28%
Tumor Progression
14%
Gene Therapy
14%
Oligonucleotide
14%
Carcinogenesis
14%
Cell Proliferation
14%
Point Mutation
14%
Antisense
14%
Cytotoxicity
14%
Adenovirus Vector
14%
Nude Mouse
14%
Titer
14%
Oncogene H Ras
14%
Cancer Model
14%